Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

06 Nov, EOD - Indian

SENSEX 80378.13 (1.13)

Nifty 50 24484.05 (1.12)

Nifty Bank 52317.4 (0.21)

Nifty IT 42039.5 (3.99)

Nifty Midcap 100 57355.8 (2.21)

Nifty Next 50 71389.8 (2.28)

Nifty Pharma 22920.35 (1.14)

Nifty Smallcap 100 18906.1 (2.18)

06 Nov, EOD - Global

NIKKEI 225 39480.67 (2.61)

HANG SENG 20538.38 (-2.23)

S&P 5953.75 (2.22)

Cancel

BSE Code : 500124 | NSE Symbol : DRREDDY | ISIN : INE089A01031 | Industry : Pharmaceuticals |

(06-Nov-24 13:05) Dr Reddys Laboratories Ltd spurts 2.25%
(05-Nov-24 17:35) Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore
(05-Nov-24 17:09) Dr Reddy's Laboratories consolidated net profit declines 15.28% in the September 2024 quarter
(08-Oct-24 18:16) Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel
(05-Oct-24 11:37) Dr Reddys announces incorporation of new step-down subsidiary in Denmark
(30-Sep-24 17:31) Dr Reddys acquires Haleon plc brands in NRT category
(23-Sep-24 10:11) Dr Reddys Laboratories schedules board meeting
(19-Sep-24 13:35) Dr Reddys Laboratories Ltd down for fifth straight session
(06-Sep-24 13:35) Dr Reddys Laboratories Ltd eases for fifth straight session
(06-Sep-24 12:15) Dr Reddy’s Labs Andhra Pradesh facility gets EIR from USFDA

1 2 3 4 5 6 7 8 9 10

Dr Reddys Laboratories Ltd